APO Research
Talk to an analyst

APO RESEARCH · REPORT

Neurotensin

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Neurotensin Market Outlook and Growth Opportunities 2026

30 December 2025195 pages

Choose your research edition.

Industry ResearchNeurotensin Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Neurotensin Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Neurotensin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Neurotensin Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Neurotensin Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Neurotensin market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Neurotensin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Neurotensin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Neurotensin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Neurotensin market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Neurotensin market include APExBIO, Bio - Techne, Eurogentec, Genscript, MedChemExpress, Peptide Institute and PerkinElmer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Neurotensin market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Neurotensin and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Neurotensin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Neurotensin market size, projected growth trends, production technologies, key applications, and end-use industries.

Neurotensin Segment by Company

APExBIO

Bio - Techne

Eurogentec

Genscript

MedChemExpress

Peptide Institute

PerkinElmer

Neurotensin Segment by Type

Bovine

Canine

Human

Mouse

Neurotensin Segment by Application

Scientific Research

Medical

Others

Neurotensin Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Neurotensin status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Neurotensin market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Neurotensin significant trends, drivers, influence factors in global and regions.

6. To analyze Neurotensin competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neurotensin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Neurotensin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neurotensin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Neurotensin market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Neurotensin industry.

Chapter 3: Detailed analysis of Neurotensin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Neurotensin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Neurotensin in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Neurotensin Industry Trends Table 2. Neurotensin Industry Drivers Table 3. Neurotensin Industry Opportunities and Challenges Table 4. Neurotensin Industry Restraints Table 5. Global Neurotensin Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Neurotensin Revenue Share by Company (2021-2026) Table 7. Global Neurotensin Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Neurotensin Sales Volume Share by Company (2021-2026) Table 9. Global Neurotensin Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Neurotensin Company Ranking, (2024-2026) & (USD Million) Table 11. Global Neurotensin Key Company Manufacturing Base & Headquarters Table 12. Global Neurotensin Company, Product Type & Application Table 13. Global Neurotensin Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Neurotensin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Bovine Table 18. Significant Companies of Canine Table 19. Significant Companies of Human Table 20. Significant Companies of Mouse Table 21. Global Neurotensin Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Neurotensin Sales Volume by Type (2021-2026) & (K Units) Table 23. Global Neurotensin Sales Volume by Type (2027-2032) & (K Units) Table 24. Global Neurotensin Sales Volume Share by Type (2021-2026) Table 25. Global Neurotensin Sales Volume Share by Type (2027-2032) Table 26. Global Neurotensin Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Neurotensin Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Neurotensin Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Neurotensin Sales Value Share by Type (2021-2026) Table 30. Global Neurotensin Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Scientific Research Table 32. Significant Companies of Medical Table 33. Significant Companies of Others Table 34. Global Neurotensin Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Neurotensin Sales Volume by Application (2021-2026) & (K Units) Table 36. Global Neurotensin Sales Volume by Application (2027-2032) & (K Units) Table 37. Global Neurotensin Sales Volume Share by Application (2021-2026) Table 38. Global Neurotensin Sales Volume Share by Application (2027-2032) Table 39. Global Neurotensin Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Neurotensin Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Neurotensin Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Neurotensin Sales Value Share by Application (2021-2026) Table 43. Global Neurotensin Sales Value Share by Application (2027-2032) Table 44. Global Neurotensin Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Neurotensin Sales by Region (2021-2026) & (K Units) Table 46. Global Neurotensin Sales Market Share by Region (2021-2026) Table 47. Global Neurotensin Sales by Region (2027-2032) & (K Units) Table 48. Global Neurotensin Sales Market Share by Region (2027-2032) Table 49. Global Neurotensin Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Neurotensin Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Neurotensin Sales Value Share by Region (2021-2026) Table 52. Global Neurotensin Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Neurotensin Sales Value Share by Region (2027-2032) Table 54. Global Neurotensin Market Average Price (US$/Unit) by Region (2021-2026) Table 55. Global Neurotensin Market Average Price (US$/Unit) by Region (2027-2032) Table 56. Global Neurotensin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Global Neurotensin Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Neurotensin Sales by Country (2021-2026) & (K Units) Table 59. Global Neurotensin Sales Market Share by Country (2021-2026) Table 60. Global Neurotensin Sales by Country (2027-2032) & (K Units) Table 61. Global Neurotensin Sales Market Share by Country (2027-2032) Table 62. Global Neurotensin Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Neurotensin Sales Value Market Share by Country (2021-2026) Table 64. Global Neurotensin Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Neurotensin Sales Value Market Share by Country (2027-2032) Table 66. APExBIO Company Information Table 67. APExBIO Business Overview Table 68. APExBIO Neurotensin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. APExBIO Neurotensin Product Portfolio Table 70. APExBIO Recent Development Table 71. Bio - Techne Company Information Table 72. Bio - Techne Business Overview Table 73. Bio - Techne Neurotensin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Bio - Techne Neurotensin Product Portfolio Table 75. Bio - Techne Recent Development Table 76. Eurogentec Company Information Table 77. Eurogentec Business Overview Table 78. Eurogentec Neurotensin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Eurogentec Neurotensin Product Portfolio Table 80. Eurogentec Recent Development Table 81. Genscript Company Information Table 82. Genscript Business Overview Table 83. Genscript Neurotensin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Genscript Neurotensin Product Portfolio Table 85. Genscript Recent Development Table 86. MedChemExpress Company Information Table 87. MedChemExpress Business Overview Table 88. MedChemExpress Neurotensin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. MedChemExpress Neurotensin Product Portfolio Table 90. MedChemExpress Recent Development Table 91. Peptide Institute Company Information Table 92. Peptide Institute Business Overview Table 93. Peptide Institute Neurotensin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Peptide Institute Neurotensin Product Portfolio Table 95. Peptide Institute Recent Development Table 96. PerkinElmer Company Information Table 97. PerkinElmer Business Overview Table 98. PerkinElmer Neurotensin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. PerkinElmer Neurotensin Product Portfolio Table 100. PerkinElmer Recent Development Table 101. Key Raw Materials Table 102. Raw Materials Key Suppliers Table 103. Neurotensin Distributors List Table 104. Neurotensin Customers List Table 105. Research Programs/Design for This Report Table 106. Authors List of This Report Table 107. Secondary Sources Table 108. Primary Sources List of Figures Figure 1. Neurotensin Product Image Figure 2. Global Neurotensin Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Neurotensin Sales Value (2021-2032) & (US$ Million) Figure 4. Global Neurotensin Sales (2021-2032) & (K Units) Figure 5. Global Neurotensin Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Neurotensin Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Bovine Image Figure 10. Canine Image Figure 11. Human Image Figure 12. Mouse Image Figure 13. Global Neurotensin Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Neurotensin Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Neurotensin Sales Volume Share by Type (2021-2032) Figure 16. Global Neurotensin Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Neurotensin Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Neurotensin Sales Value Share by Type (2021-2032) Figure 19. Scientific Research Image Figure 20. Medical Image Figure 21. Others Image Figure 22. Global Neurotensin Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Neurotensin Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Neurotensin Sales Volume Share by Application (2021-2032) Figure 25. Global Neurotensin Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Neurotensin Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Neurotensin Sales Value Share by Application (2021-2032) Figure 28. Global Neurotensin Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 29. Global Neurotensin Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Neurotensin Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Neurotensin Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Neurotensin Sales Value (2021-2032) & (US$ Million) Figure 33. North America Neurotensin Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Neurotensin Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Neurotensin Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Neurotensin Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Neurotensin Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Neurotensin Sales Value (2021-2032) & (US$ Million) Figure 39. South America Neurotensin Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Neurotensin Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Neurotensin Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Neurotensin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Neurotensin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Neurotensin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Neurotensin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Neurotensin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Neurotensin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Neurotensin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Neurotensin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Neurotensin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Neurotensin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Neurotensin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Neurotensin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Neurotensin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Neurotensin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Neurotensin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Neurotensin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Neurotensin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Neurotensin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Neurotensin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Neurotensin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Neurotensin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Neurotensin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Neurotensin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Neurotensin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Neurotensin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Neurotensin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Neurotensin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Neurotensin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Neurotensin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Neurotensin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Neurotensin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Neurotensin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Neurotensin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Neurotensin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Neurotensin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Neurotensin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Neurotensin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Neurotensin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Neurotensin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Neurotensin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Neurotensin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Neurotensin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Neurotensin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Neurotensin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Neurotensin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Neurotensin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Neurotensin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Neurotensin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Neurotensin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Neurotensin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Neurotensin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Neurotensin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Neurotensin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Neurotensin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Neurotensin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Neurotensin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Neurotensin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Neurotensin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Neurotensin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Neurotensin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Neurotensin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Neurotensin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Neurotensin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Neurotensin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Neurotensin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Neurotensin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Neurotensin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Neurotensin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Neurotensin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Neurotensin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Neurotensin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Neurotensin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Neurotensin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Neurotensin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Neurotensin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Neurotensin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Neurotensin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Neurotensin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Neurotensin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Neurotensin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Neurotensin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Neurotensin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Neurotensin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Neurotensin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Neurotensin Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Neurotensin Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Bovine
  • Canine
  • Human
  • Mouse
Applications
  • Scientific Research
  • Medical
  • Others
Companies covered
  • APExBIO
  • Bio - Techne
  • Eurogentec
  • Genscript
  • MedChemExpress
  • Peptide Institute
  • PerkinElmer

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Neurotensin Sales Value (2021-2032)
  4. 1.2.2 Global Neurotensin Sales Volume (2021-2032)
  5. 1.2.3 Global Neurotensin Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Neurotensin Market Dynamics
  1. 2.1 Neurotensin Industry Trends
  2. 2.2 Neurotensin Industry Drivers
  3. 2.3 Neurotensin Industry Opportunities and Challenges
  4. 2.4 Neurotensin Industry Restraints
3 Neurotensin Market by Company
  1. 3.1 Global Neurotensin Company Revenue Ranking in 2025
  2. 3.2 Global Neurotensin Revenue by Company (2021-2026)
  3. 3.3 Global Neurotensin Sales Volume by Company (2021-2026)
  4. 3.4 Global Neurotensin Average Price by Company (2021-2026)
  5. 3.5 Global Neurotensin Company Ranking (2024-2026)
  6. 3.6 Global Neurotensin Company Manufacturing Base and Headquarters
  7. 3.7 Global Neurotensin Company Product Type and Application
  8. 3.8 Global Neurotensin Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Neurotensin Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Neurotensin Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Neurotensin Market by Type
  1. 4.1 Neurotensin Type Introduction
  2. 4.1.1 Bovine
  3. 4.1.2 Canine
  4. 4.1.3 Human
  5. 4.1.4 Mouse
  6. 4.2 Global Neurotensin Sales Volume by Type
  7. 4.2.1 Global Neurotensin Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Neurotensin Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Neurotensin Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Neurotensin Sales Value by Type
  11. 4.3.1 Global Neurotensin Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Neurotensin Sales Value by Type (2021-2032)
  13. 4.3.3 Global Neurotensin Sales Value Share by Type (2021-2032)
5 Neurotensin Market by Application
  1. 5.1 Neurotensin Application Introduction
  2. 5.1.1 Scientific Research
  3. 5.1.2 Medical
  4. 5.1.3 Others
  5. 5.2 Global Neurotensin Sales Volume by Application
  6. 5.2.1 Global Neurotensin Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Neurotensin Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Neurotensin Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Neurotensin Sales Value by Application
  10. 5.3.1 Global Neurotensin Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Neurotensin Sales Value by Application (2021-2032)
  12. 5.3.3 Global Neurotensin Sales Value Share by Application (2021-2032)
6 Neurotensin Regional Sales and Value Analysis
  1. 6.1 Global Neurotensin Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Neurotensin Sales by Region (2021-2032)
  3. 6.2.1 Global Neurotensin Sales by Region: 2021-2026
  4. 6.2.2 Global Neurotensin Sales by Region (2027-2032)
  5. 6.3 Global Neurotensin Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Neurotensin Sales Value by Region (2021-2032)
  7. 6.4.1 Global Neurotensin Sales Value by Region: 2021-2026
  8. 6.4.2 Global Neurotensin Sales Value by Region (2027-2032)
  9. 6.5 Global Neurotensin Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Neurotensin Sales Value (2021-2032)
  12. 6.6.2 North America Neurotensin Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Neurotensin Sales Value (2021-2032)
  15. 6.7.2 Europe Neurotensin Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Neurotensin Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Neurotensin Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Neurotensin Sales Value (2021-2032)
  21. 6.9.2 South America Neurotensin Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Neurotensin Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Neurotensin Sales Value Share by Country, 2025 VS 2032
7 Neurotensin Country-level Sales and Value Analysis
  1. 7.1 Global Neurotensin Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Neurotensin Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Neurotensin Sales by Country (2021-2032)
  4. 7.3.1 Global Neurotensin Sales by Country (2021-2026)
  5. 7.3.2 Global Neurotensin Sales by Country (2027-2032)
  6. 7.4 Global Neurotensin Sales Value by Country (2021-2032)
  7. 7.4.1 Global Neurotensin Sales Value by Country (2021-2026)
  8. 7.4.2 Global Neurotensin Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Neurotensin Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Neurotensin Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Neurotensin Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Neurotensin Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Neurotensin Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Neurotensin Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Neurotensin Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Neurotensin Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Neurotensin Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Neurotensin Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Neurotensin Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Neurotensin Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Neurotensin Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Neurotensin Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Neurotensin Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Neurotensin Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Neurotensin Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Neurotensin Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Neurotensin Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Neurotensin Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Neurotensin Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Neurotensin Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Neurotensin Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Neurotensin Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Neurotensin Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Neurotensin Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Neurotensin Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Neurotensin Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Neurotensin Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Neurotensin Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Neurotensin Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Neurotensin Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Neurotensin Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Neurotensin Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Neurotensin Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Neurotensin Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Neurotensin Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Neurotensin Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Neurotensin Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Neurotensin Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Neurotensin Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Neurotensin Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Neurotensin Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Neurotensin Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Neurotensin Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Neurotensin Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Neurotensin Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Neurotensin Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Neurotensin Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Neurotensin Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Neurotensin Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Neurotensin Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Neurotensin Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Neurotensin Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Neurotensin Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Neurotensin Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Neurotensin Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Neurotensin Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Neurotensin Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Neurotensin Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Neurotensin Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Neurotensin Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Neurotensin Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Neurotensin Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Neurotensin Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Neurotensin Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Neurotensin Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Neurotensin Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Neurotensin Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Neurotensin Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Neurotensin Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Neurotensin Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Neurotensin Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Neurotensin Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Neurotensin Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Neurotensin Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Neurotensin Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Neurotensin Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Neurotensin Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Neurotensin Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Neurotensin Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Neurotensin Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Neurotensin Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Neurotensin Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 APExBIO
  2. 8.1.1 APExBIO Company Information
  3. 8.1.2 APExBIO Business Overview
  4. 8.1.3 APExBIO Neurotensin Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 APExBIO Neurotensin Product Portfolio
  6. 8.1.5 APExBIO Recent Developments
  7. 8.2 Bio - Techne
  8. 8.2.1 Bio - Techne Company Information
  9. 8.2.2 Bio - Techne Business Overview
  10. 8.2.3 Bio - Techne Neurotensin Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Bio - Techne Neurotensin Product Portfolio
  12. 8.2.5 Bio - Techne Recent Developments
  13. 8.3 Eurogentec
  14. 8.3.1 Eurogentec Company Information
  15. 8.3.2 Eurogentec Business Overview
  16. 8.3.3 Eurogentec Neurotensin Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Eurogentec Neurotensin Product Portfolio
  18. 8.3.5 Eurogentec Recent Developments
  19. 8.4 Genscript
  20. 8.4.1 Genscript Company Information
  21. 8.4.2 Genscript Business Overview
  22. 8.4.3 Genscript Neurotensin Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Genscript Neurotensin Product Portfolio
  24. 8.4.5 Genscript Recent Developments
  25. 8.5 MedChemExpress
  26. 8.5.1 MedChemExpress Company Information
  27. 8.5.2 MedChemExpress Business Overview
  28. 8.5.3 MedChemExpress Neurotensin Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 MedChemExpress Neurotensin Product Portfolio
  30. 8.5.5 MedChemExpress Recent Developments
  31. 8.6 Peptide Institute
  32. 8.6.1 Peptide Institute Company Information
  33. 8.6.2 Peptide Institute Business Overview
  34. 8.6.3 Peptide Institute Neurotensin Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Peptide Institute Neurotensin Product Portfolio
  36. 8.6.5 Peptide Institute Recent Developments
  37. 8.7 PerkinElmer
  38. 8.7.1 PerkinElmer Company Information
  39. 8.7.2 PerkinElmer Business Overview
  40. 8.7.3 PerkinElmer Neurotensin Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 PerkinElmer Neurotensin Product Portfolio
  42. 8.7.5 PerkinElmer Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Neurotensin Value Chain Analysis
  2. 9.1.1 Neurotensin Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Neurotensin Sales Mode & Process
  6. 9.2 Neurotensin Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Neurotensin Distributors
  9. 9.2.3 Neurotensin Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst